BAXTER INTERNATIONAL INC. Société Baxter International Inc.
Actions
BAX
US0718131099
Equipement, fournitures et distribution médicale
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 35,17 USD | -0,73 % |
|
-2,17 % | -9,03 % |
Métier
- médicaments et dispositifs médicaux (33,8%) : produits destinés au traitement de l'hémophilie (facteurs de coagulation de substitution) et des déficits immunitaires (immunoglobines polyvalentes), et utilisés lors des soins intensifs (albumine humaine) et en biochirurgie (colle de fibrine, gel chirurgical, substituts osseux, compresses hémostatiques, etc.) ;
- médicaments et matériels de dialyse rénale (30,1%) ;
- systèmes de délivrance de médicaments et de thérapie intraveineuse (15,2%) : utilisés dans les domaines de l'anesthésie, de l'oncologie (chimiothérapie et radiothérapie), de la nutrition parentérale, etc. ;
- autres (20,1%).
52,7% du CA est réalisé à l'étranger.
Nombre d'employés: 60 000
Ventes par activité
| USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
Medical Products and Therapies
33,8
%
| - | - | 5 011 | 33,8 % | - |
Kidney Care
30,1
%
| - | - | 4 453 | 30,1 % | - |
Healthcare Systems and Technologies
20,3
%
| - | - | 3 013 | 20,3 % | - |
Pharmaceuticals
15,2
%
| - | - | 2 249 | 15,2 % | - |
Other
0,6
%
| - | - | 87 | 0,6 % | - |
Ventes par région
| USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
United States
47,3
%
| 7 223 | 47,8 % | 7 000 | 47,3 % | -3,09 % |
Rest of World
30,3
%
| - | - | 4 494 | 30,3 % | - |
Emerging Markets
22,4
%
| - | - | 3 319 | 22,4 % | - |
Dirigeants
| Dirigeants | Titre | Age | Depuis |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 01/10/15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 18/10/23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Tobi Karchmer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Heather Knight
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Clare Trachtman
IRC | Investor Relations Contact | - | 01/01/00 |
David Rosenbloom
LAW | General Counsel | - | 01/01/22 |
Darren Evans
PRN | Corporate Officer/Principal | - | 01/12/21 |
Heather Wechet
HRO | Human Resources Officer | - | 01/06/08 |
Lynn Pawelski
LAW | General Counsel | - | 01/04/18 |
Administrateurs
| Administrateurs | Titre | Age | Depuis |
|---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 06/02/17 |
Peter Wilver
BRD | Director/Board Member | 64 | 10/05/22 |
| Director/Board Member | 64 | 18/02/19 | |
| Director/Board Member | 63 | 01/01/19 | |
Joe Almeida
CEO | Chief Executive Officer | 61 | 01/10/15 |
Catherine Smith
BRD | Director/Board Member | 60 | 18/07/17 |
| Director/Board Member | 69 | 13/12/21 | |
| Director/Board Member | 66 | 21/08/23 | |
David Wilkes
BRD | Director/Board Member | 67 | 15/02/21 |
D. Shafer
BRD | Director/Board Member | 66 | 10/05/22 |
Classe d'actions
| Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
|---|---|---|---|---|---|
| Action A | 1 | 685 442 083 | 507 613 362 ( 74,06 %) | 0 | 74,06 % |
Participations
| Nom | Actions | % | Valorisation |
|---|---|---|---|
ALVOTECH 1,03% | 2 735 145 | 1,03% | 37 334 729 $ |
Coordonnées société
Sociétés du groupe
| Nom | Catégorie et Secteur |
|---|---|
Baxter (India) Pvt Ltd.
 Baxter (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Baxter (India) Pvt Ltd. manufactures recombinant and plasma-based proteins that are used to treat hemophilia and other bleeding disorders in India. The firm also offers plasma based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shocks, and other chronic and acute blood related conditions. It offers products to healthcare professionals, patients, and caregivers in the areas of anaesthesia, biosurgery, clinical nutrition, critical care, haemophilia, infusion systems, pharmaceuticals and IV solutions, renal, kidney disease, and immune deficiency. The company is headquartered in Gurgaon, India. |
Pharmaceuticals: Major
|
Baxter Innovations & Business Solutions Pvt Ltd.
| |
Baxter Pharmaceuticals India Pvt Ltd.
 Baxter Pharmaceuticals India Pvt Ltd. Chemicals: Major DiversifiedProcess Industries Founded in 2005, Baxter Pharmaceuticals India Pvt Ltd. is a subsidiary of Baxter International, Inc. that manufactures chemical products. The company is based in Ahmedabad, India. |
Chemicals: Major Diversified
|
Gambro Lundia AB
 Gambro Lundia AB Medical DistributorsDistribution Services Gambro Lundia AB operates as a medical technology company. It develops, manufactures, and distributes products and treatments for kidney and liver dialysis, treatment of myeloma kidney, and other extracorporeal treatments for chronically and acutely ill patients. The firm also holds shares in other companies. The company was founded on February 18, 1953 and is headquartered in Lund, Sweden. |
Medical Distributors
|
Baxter (Malta) Trading Co. Ltd.
| |
Baxter World Trade SRL
 Baxter World Trade SRL Miscellaneous Commercial ServicesCommercial Services Founded in 1984, Baxter World Trade SRL is a Belgian company that provides management services. Part of Baxter International, Inc., the company is based in Lessines, Belgium. |
Miscellaneous Commercial Services
|
Baxter R & D Europe SRL
 Baxter R & D Europe SRL Medical/Nursing ServicesHealth Services Founded in 1954, Baxter R & D Europe SRL is a subsidiary of Baxter International, Inc. that provides healthcare services. The company is based in Braine-l'Alleud, Belgium. |
Medical/Nursing Services
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
| Varia. 1 janv. | Capi. | |
|---|---|---|
| -9,03 % | 18,05 Md | |
| -4,72 % | 182 Md | |
| +3,96 % | 112 Md | |
| -2,93 % | 68,58 Md | |
| +6,30 % | 51,58 Md | |
| +8,02 % | 44,24 Md | |
| +9,45 % | 43,65 Md | |
| +26,18 % | 32,46 Md | |
| +20,94 % | 25,99 Md | |
| +0,57 % | 25,61 Md |
- Bourse
- Actions
- Action BAX
- Société Baxter International Inc.
